Non-invasive monitoring of patients' therapy is an attractive concept. Patients with the inherited disorder phenylketonuria (PKU) require regular determination of phenylalanine concentrations in order to monitor the ef®cacy of their dietary phenylalanine restriction. We decided to investigate the possibility that salivary phenylalanine concentrations might re¯ect blood phenylalanine concentrations suf®ciently closely to replace them as the monitoring tool for children old enough to salivate on demand.
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Ten PKU children and one non-PKU adult volunteered to cleanse their mouth with a water rinse and then salivate into a Universal pot. Blood for phenylalanine estimation was obtained at the same time in seven individuals. For the others, a blood phenylalanine concentration as closely matched in time to when the patient provided the saliva was used as a comparison. The salivary and blood phenylalanine concentrations were measured using our routine high-performance liquid chromatography procedure. 1 The mean blood phenylalanine concentration was 432 mol/L (range: 90±730 mol/L) and the mean salivary phenylalanine concentration was 61 mol/L (range: 16±111 mol/L) The lowest results were obtained in the normal individual. The correlation coef®cient (r) was 0´69 (P 0´02). The regression of plasma on saliva had a slope of 4´64, 95% con®dence interval of 0´95 to 8´32, intercept of 152 mol/L and a mean plasma : saliva ratio of 7´1:1. If the data are re-
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Ann Clin Biochem 2000; 37: 222±223 analysed excluding the specimens that were not collected concurrently, the results are not signi®cantly different. Although the regression line for salivary phenylalanine concentration could predict the blood phenylalanine concentration, the error of prediction would be so wide as to render the result unusable.
There are very few data in the literature on human salivary amino acid concentrations. 2, 3 We are not aware of any reports that compare human plasma and salivary phenylalanine concentrations in PKU patients. In conclusion, although salivary phenylalanine concentrations do appear to correlate with blood concentrations in patients with PKU, the correlation coef®cient is too low for them to be of practical value as an alternative measure to blood concentrations for routine monitoring.
